Search by Drug Name or NDC
NDC 67618-0200-30 BETASEPT 0.04 mg/mL Details
BETASEPT 0.04 mg/mL
BETASEPT is a TOPICAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Atlantis Consumer Healthcare, Inc.. The primary component is CHLORHEXIDINE GLUCONATE.
Product Information
NDC | 67618-0200 |
---|---|
Product ID | 67618-200_38dcb5ed-dbcd-42dd-9851-23061fed37b1 |
Associated GPIs | 92100030100940 |
GCN Sequence Number | 007254 |
GCN Sequence Number Description | chlorhexidine gluconate LIQUID 4 % TOPICAL |
HIC3 | Q5B |
HIC3 Description | TOPICAL PREPARATIONS,ANTIBACTERIALS |
GCN | 30011 |
HICL Sequence Number | 004297 |
HICL Sequence Number Description | CHLORHEXIDINE GLUCONATE |
Brand/Generic | Generic |
Proprietary Name | BETASEPT |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Antiseptic Surgical Scrub |
Product Type | HUMAN OTC DRUG |
Dosage Form | SOLUTION |
Route | TOPICAL |
Active Ingredient Strength | 0.04 |
Active Ingredient Units | mg/mL |
Substance Name | CHLORHEXIDINE GLUCONATE |
Labeler Name | Atlantis Consumer Healthcare, Inc. |
Pharmaceutical Class | Decreased Cell Wall Integrity [PE] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA019125 |
Listing Certified Through | 2024-12-31 |
Package
NDC 67618-0200-30 (67618020030)
NDC Package Code | 67618-200-30 |
---|---|
Billing NDC | 67618020030 |
Package | 946 mL in 1 BOTTLE (67618-200-30) |
Marketing Start Date | 1993-06-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |